The Metabolomics Market was estimated at US$ 2.3 billion in 2021 and is expected to grow at a CAGR of 14.86% during 2022-2028 to reach US$ 6.18 billion in 2028. North America is the largest market for metabolomics, while the Asia-Pacific region is expected to experience the fastest growth rate during the forecast period.